Neuroscience

Apollo Neuroscience Announces Publication of Landmark Clinical Study Demonstrating Apollo Wearable Use Yields an Average of 46 More Minutes of Sleep Per Night

Former Client and Three-Decade Data Sciences Leader John Reynders, PhD, Joins Rancho BioSciences Leadership on Board of Directors

This appointment reflects the company's continued growth through investment in leadership that pairs deep scientific credibility with real-world R&D experience...

Dysport® is the first botulinum toxin to achieve positive topline Phase III results in both episodic and chronic migraine.

Dysport® achieved statistically significant topline Phase III results, meeting primary endpoints in both episodic (E-BEOND) and chronic (C-BEOND) migraineDysport is...

Active Motif Announces Exclusive Global Distribution Agreement with Arima Genomics for Advanced 3D Genomics Solutions

Agreement expands Active Motif's research genomics portfolio while supporting Arima's strategic focus on its clinical diagnostics platform CARLSBAD, Calif., July...

Remepy Publishes New Evidence Showing its Hybrid Drug, Hybridopa™, Effect on Structural Connectivity in the Brain of Parkinson’s Patients Associated with Improved Clinical Outcome

New npj Parkinson's Disease publication, building on the previously reported Hybridopa™ Phase IIa results, demonstrates for the first time, that...

Magnetic Resonance Imaging (MRI) Market to Reach USD 10.2 Billion by 2036 as AI Reconstruction and Low-Helium Systems Improve Imaging Efficiency | FMI

NEWARK, Del., June 30, 2026 /PRNewswire/ -- The global Magnetic Resonance Imaging (MRI) Market, according to Future Market Insights, is...

FHIMA Celebrates 50th Annual Convention with “Reach for the Stars” Theme, Nationally Recognized Keynote Speakers, and Interactive Healthcare Innovations

Florida's premier health information management conference welcomes hundreds of healthcare professionals to Orlando, July 12–15, 2026.ORLANDO, Fla., June 30, 2026...

error: Content is protected !!